Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors — Stella

Home/Adult Gynecological Tumors/Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

View on ClinicalTrials.gov

Recruiting

Back to Adult Gynecological Tumors trials

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

China

Shanghai Jiaotong University School of Medcine, Renji Hospital Ethica Committee, Shanghai, Shanghai Municipality

Key details

Phase

Very early testing

Sponsor

Grit Biotechnology

Enrollment target

~26 participants

Started

November 2022

Primary completion

October 2026

Age range

18 Years – 70 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.